The PolyPeptide Group is a privately-held Contract Development & Manufacturing Organization (CDMO) which focuses on proprietary and generic GMP-grade peptides for the pharmaceutical and biotechnology markets.
As one of the world’s largest independent contract manufacturers of therapeutic peptides, the Group manufactures over one third of all approved peptide drug substances. With six GMP facilities worldwide, France, India, Belgium, Sweden and the USA , a leading position in its field with a focus on pharmaceutical peptide manufacture, PolyPeptide Group offers its customers core expertise and an unprecedented long-term security of supply.
Our mission is to create customer satisfaction and foster long-term customer loyalty through excellence in peptide technology, quality, value, service and customer support.
Our goal is to assist our clients at every step of product development; from early stage development to commercial GMP grade manufacturing.
Our customers are our focus. We strive to be your preferred partner from simple to complex peptide manufacturing by consistently providing you with the highest quality products and services.